Oncology & Cancer

First made-in-Singapore cancer drug enters clinical testing

A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. ...

Alzheimer's disease & dementia

Past failures pave way for promising new Alzheimer's treatments

Since 2002, close to 300 drug candidates to treat Alzheimer's have run into clinical dead ends. But now, having learned from those failures, researchers are testing—and retesting—a batch of the most promising compounds ...

Diseases, Conditions, Syndromes

Experimental Ebola treatment boosts survival in mice

The number of new Ebola cases is tapering off, but the search for new treatments continues. Now, one research team has found potential drug candidates that successfully treated up to 90 percent of mice exposed to the Ebola ...

Medications

Fast-tracking rare disease drug candidates' approval

Aspiring new drugs face long and stringent tests on safety and effectiveness before making it to market. And rightly so. But giving drugs special designations that bring with them the right incentives can help bring them ...

page 11 from 20